Literature DB >> 4603037

Sulfalene with pyrimethamine and chloroquine with pyrimethamine in single-dose treatment of Plasmodium falciparum infections. A trial in a rural population in northern Nigeria.

J Storey, A Rossi-Espagnet, S P Mandel, T Matsushima, P Lietaert, D Thomas, S Brogger, C Duby, G Gramiccia.   

Abstract

A comparative trial was carried out in northern Nigeria of the ability of the drug combinations chloroquine-pyrimethamine and sulfalene-pyrimethamine to clear the peripheral blood stream of asexual forms of P. falciparum within 7 days. The reappearance of asexual P. falciparum forms within the 70-day follow-up period and the occurrence of vomiting during the 2-3 hours following administration of the drugs were also recorded. The purpose of the trial was to choose the more suitable of the two drug combinations for repeated mass administration in the intervention phase of a collaborative field research project in the epidemiology and control of malaria in the African savannah. No differences were observed between the two drug combinations from a parasitological point of view. However, the sulfalene-pyrimethamine combination was found easier to administer and occasioned fewer records of vomiting. It was therefore recommended for use in the project.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4603037      PMCID: PMC2481143     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  The estimation of sample size in experiments. II. Using comparisons of proportions.

Authors:  N W CHILTON; J W FERTIG
Journal:  J Dent Res       Date:  1953-10       Impact factor: 6.116

2.  Evaluation of synthetic anti-malarial drugs in children from a hyperendemic area in West Africa.

Authors:  L J BRUCE-CHWATT
Journal:  Trans R Soc Trop Med Hyg       Date:  1951-04       Impact factor: 2.184

3.  Antimalarial activity of Kelfizina-trimethoprim and Kelfizina-pyrimethamine versus chloroquine in field trials in Nigeria.

Authors:  L Donno; V Sanguineti; M L Ricciardi; M Soldati
Journal:  Am J Trop Med Hyg       Date:  1969-03       Impact factor: 2.345

  3 in total
  2 in total

1.  A brief history of the cluster randomised trial design.

Authors:  Jenny Moberg; Michael Kramer
Journal:  J R Soc Med       Date:  2015-05       Impact factor: 5.344

2.  Antiplasmodial efficacy of 2,4--diaminopyrimidine0sylfonamide combinations, especially against chloroquine-resistant malaria.

Authors:  I M Rollo
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.